priors.science/reviews/copd-pharmacotherapy

COPD Pharmacotherapy

The current evidence on 16 claims, ordered from most established to most contested. Each score is the panel’s evidence certainty — how firmly the literature supports the claim as stated.

16claims tracked
129primary papers reviewed
5 Jun 2026latest evidence review
Weeklyre-scored against new papers
5 Established · 5 Likely · 4 Uncertain · 2 Doubtful  |  four-reviewer panel · PICO Framework
SignalClaimStandingEvidence certaintyCorpus
StableLong-acting muscarinic antagonists reduce exacerbationsBronchodilatorsEstablished90%8
StableDual bronchodilation improves FEV1BronchodilatorsEstablished87%10
StableTriple therapy cuts exacerbationsTriple TherapyEstablished87%11
StableInhaled corticosteroids raise pneumonia riskIcs RiskEstablished86%11
StableSteroids shorten exacerbation recoveryExacerbation ManagementEstablished85%8
StableDupilumab cuts exacerbationsBiologicsLikely74%10
StableAzithromycin reduces exacerbationsExacerbation ManagementLikely73%9
StableSingle-inhaler triple therapy adherenceTriple TherapyLikely69%12
StableLong-acting muscarinic antagonist plus beta-agonist vs beta-agonist plus inhaled corticosteroid exacerbationsBronchodilatorsLikely67%9
StableRoflumilast in severe chronic obstructive pulmonary diseaseExacerbation ManagementLikely65%9
StableEnsifentrine add-on therapyEmerging TherapiesUncertain60%8
StableEosinophils predict inhaled corticosteroid responseIcs RiskUncertain60%9
StableTriple therapy mortality benefitTriple TherapyUncertain58%9
StableMepolizumab in eosinophilic chronic obstructive pulmonary diseaseBiologicsUncertain57%8
StableInhaled corticosteroid withdrawal and exacerbationsIcs RiskDoubtful35%11
StableTezepelumab in chronic obstructive pulmonary diseaseEmerging TherapiesDoubtful32%3
Standing — what the evidence certainty means
Established≥ 85%Strong, consistent evidence. Unlikely to change.
Likely65–84%Well supported, with some gaps or indirect evidence.
Uncertain40–64%Mixed or limited evidence. Genuinely open.
Doubtful15–39%Little support; the weight of evidence leans against it.
Refuted< 15%The evidence contradicts it — confidently false as stated.
Recent signal
strengthenedNew evidence raised the certainty since the last review.
weakenedNew evidence lowered the certainty since the last review.
newA claim added to the review recently.
StableNo recent change to the standing.
Standing, evidence certainty and corpus are always shown. The study behind each move, why it moved, and the sceptic’s challenge are delivered to subscribers.
Update your priors.Track this topic